参考文献
-
1) Development of cell-permeable and plasma-stable peptidomimetic inhibitors against PSD-95/nNOS interaction as potential anti-ischemic stroke agents.
-
2) Design, synthesis and bioevaluation of novel hydrazide derivatives as enhancers of immunotherapy and DNA-damage response in antitumor therapy.
-
3) Bavachin ameliorates cisplatin-induced nephrotoxicity by enhancing mitochondrial β-oxidation and lipid metabolism through MFN2.
-
4) Vitexin alleviates lipid metabolism disorders and hepatic injury in obese mice through the PI3K/AKT/mTOR/SREBP-1c pathway.
-
5) COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis.
-
6) Genomic and Phenotypic Characterization of CHO 4BGD Cells with Quad Knockout and Overexpression of Two Housekeeping Genes That Allow for Metabolic Selection and Extended Fed-Batch Culturing.
-
7) DNA Methylation Mediates the Transcription of STAT4 to Regulate KISS1 During Follicular Development.
-
8) Sodium-Glucose Cotransporter-2 Inhibitor Improves Renal Injury by Regulating the Redox Profile, Inflammatory Parameters, and Pyroptosis in an Experimental Model of Diabetic Kidney Disease.
-
9) Ortho-Hydroxyanilides: Slow-Acting, Selective Histone Deacetylase 1/2 Inhibitors Suitable for Photocaging Applications.
-
10) FXR acts as a therapeutic target for ulcerative colitis via suppressing ferroptosis.
-
11) Targeting JAK2/STAT3-Dependent Macrophage Polarization by Chlorogenic Acid Attenuates Hepatic Inflammation in Chronic Stress.
-
12) Development of novel 18F-labelled FAP-targeting tracers with improved pharmacokinetics: From preclinical optimization to clinical translation.
-
13) Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1.
-
14) Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR.
-
15) Particulate Matter Induces Activation of Cardiac Fibroblasts via HIF1α-Mediated Autophagy.